CIK 0001178670
- Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770602661
- Phone
- +1 617-551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-18 | BRANDICOURT OLIVIER Director | Grant or award · Stock Option (right to buy) | +3,454 | 3,454 | ||
| 2023-05-18 | HAMBURG MARGARET A Director | Grant or award · Stock Option (right to buy) | +3,454 | 3,454 | ||
| 2023-05-18 | Reitan Colleen F Director | Grant or award · Stock Option (right to buy) | +3,454 | 3,454 | ||
| 2023-05-18 | SCHULMAN AMY W Director | Grant or award · Stock Option (right to buy) | +3,454 | 3,454 | ||
| 2023-05-18 | Ausiello Dennis A Director | Grant or award · Stock Option (right to buy) | +3,454 | 3,454 | ||
| 2023-05-18 | Fanucci Marsha Director | Grant or award · Stock Option (right to buy) | +3,454 | 3,454 | ||
| 2023-05-18 | BONNEY MICHAEL W Director | Grant or award · Stock Option (right to buy) | +3,454 | 3,454 | ||
| 2023-05-18 | SHARP PHILLIP A Director | Grant or award · Stock Option (right to buy) | +3,454 | 3,454 | ||
| 2023-04-28 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −204 | $195.46 | $40K | 6,596 |
| 2023-04-28 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −103 | $196.62 | $20K | 6,493 |
| 2023-04-28 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −715 | $198.03 | $142K | 5,778 |
| 2023-04-28 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −385 | $199.54 | $77K | 5,393 |
| 2023-04-28 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −955 | $200.35 | $191K | 4,438 |
| 2023-04-28 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −93 | $201.30 | $19K | 4,345 |
| 2023-04-27 | Greenstreet Yvonne Chief Executive Officer | Sale | −628 | $193.18 | $121K | 37,319 |
| 2023-04-27 | Greenstreet Yvonne Chief Executive Officer | Sale | −2,898 | $193.93 | $562K | 34,421 |
| 2023-04-27 | Greenstreet Yvonne Chief Executive Officer | Sale | −3,225 | $194.94 | $629K | 31,196 |
| 2023-04-27 | Greenstreet Yvonne Chief Executive Officer | Sale | −331 | $195.65 | $65K | 30,865 |
| 2023-04-27 | Greenstreet Yvonne Chief Executive Officer | Sale | −533 | $197.08 | $105K | 30,332 |
| 2023-04-27 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −81 | $193.18 | $16K | 12,602 |
Page 54 of 80 · 1,590 trades